Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases

Title
Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases
Authors
Keywords
-
Journal
MELANOMA RESEARCH
Volume 18, Issue 2, Pages 147-151
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2009-03-05
DOI
10.1097/cmr.0b013e3282f2a7ae

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation